127 related articles for article (PubMed ID: 28594645)
1. Novel imaging techniques in gynaecological cancer.
Vandecaveye V; Dresen R; De Keyzer F
Curr Opin Oncol; 2017 Sep; 29(5):335-342. PubMed ID: 28594645
[TBL] [Abstract][Full Text] [Related]
2. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging in gynaecological malignancy.
Addley H; Moyle P; Freeman S
Clin Radiol; 2017 Nov; 72(11):981-990. PubMed ID: 28842113
[TBL] [Abstract][Full Text] [Related]
4. Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences.
Lucas R; Lopes Dias J; Cunha TM
Diagn Interv Radiol; 2015; 21(5):368-75. PubMed ID: 26200480
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
Kuang F; Yan Z; Li H; Feng H
J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
7. [New opportunities, MRI biomarkers in the evaluation of gynaecological cancer].
Horváth K; Gõdény M
Magy Onkol; 2015 Sep; 59(3):216-27. PubMed ID: 26339911
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.
Hameeduddin A; Sahdev A
Cancer Imaging; 2015 Mar; 15(1):3. PubMed ID: 25889065
[TBL] [Abstract][Full Text] [Related]
9. What's New in Imaging for Gynecologic Cancer?
Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
[TBL] [Abstract][Full Text] [Related]
10. Functional MR imaging in gynecologic malignancies: current status and future perspectives.
Park SB
Abdom Radiol (NY); 2016 Dec; 41(12):2509-2523. PubMed ID: 27743019
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
[TBL] [Abstract][Full Text] [Related]
14. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
[TBL] [Abstract][Full Text] [Related]
16. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
17. Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor.
Kitajima K; Tanaka U; Ueno Y; Maeda T; Suenaga Y; Takahashi S; Deguchi M; Miyahara Y; Ebina Y; Yamada H; Tsurusaki M; Tamaki Y; Sugimura K
PLoS One; 2015; 10(1):e0117411. PubMed ID: 25629156
[TBL] [Abstract][Full Text] [Related]
18. Diffusion and perfusion imaging of bone marrow.
Biffar A; Dietrich O; Sourbron S; Duerr HR; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2010 Dec; 76(3):323-8. PubMed ID: 20381277
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?
Buchbender C; Hartung-Knemeyer V; Beiderwellen K; Heusch P; Kühl H; Lauenstein TC; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):877-82. PubMed ID: 23428414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
